80060969 - eHIV Review Volume 8, Issue 4: Emerging HIV Therapies and Potential Clinical Uses

Thursday, April 27, 2023, 6:30 AM - Saturday, April 26, 2025, 6:30 PM


Newsletter for clinicians treating patients with HIV

1. Discuss strategies to overcome barriers, specifically stigma, that lead to undertreatment and poor outcomes for at-risk populations.
2. Discuss strategies to overcome barriers, specifically stigma, that lead to undertreatment and poor outcomes for at-risk populations.
3. Develop plans to overcome barriers that restrict HIV testing, preventative care, and treatment for young people.
4. Develop plans to overcome barriers that restrict HIV testing, preventative care, and treatment for young people.
5. Describe the impact of stigma on the mental health of LGBTQ people and people living with HIV.
6. Describe the impact of stigma on the mental health of LGBTQ people and people living with HIV.
7. Describe clinical trial data for emerging ART and PrEP options.
8. Describe clinical trial data for emerging ART and PrEP options.
9. Assess the appropriateness of including an NNRTI in the ART regimen for certain patients.
10. Assess the appropriateness of including an NNRTI in the ART regimen for certain patients.
11. Discuss strategies that improve testing, PrEP, and HIV treatment in cisgender and transgender women.
12. Discuss strategies that improve testing, PrEP, and HIV treatment in cisgender and transgender women.

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.